Now Available – Webinars
Access our free on-demand webinars covering topics across osmolality within bioprocessing and clinical chemistry.
SCIENTIFIC LITERATURE REVIEW: THE IMPORTANCE OF MEASURING OSMOLALITY IN MONITORING & MANAGING COVID-19 PATIENTS
Abstract: Proper medical management of COVID-19 patients is vital during the pandemic to improve treatment and reduce length of stay. A growing body of evidence in the literature demonstrates that osmolality− a critical test in the diagnosis of electrolyte disorders− is an important tool in monitoring and managing COVID patients. Osmolality has long been a quick, inexpensive and effective measurement used in the treatment of electrolyte abnormalities including hyponatremia and hyperglycemia, which are characterized by low blood sodium and high blood sugar respectively. Clinical researchers around the world− from the United States to the United Kingdom and Qatar− have reported numerous case studies of patients with hyponatremia and hyperglycemia precipitated by COVID-19. As of the time of this writing, there are over 50 publications in the National Center for Biotechnology Information (NCBI) electronic database published this year referencing ‘osmolality’ and ‘COVID’. This resource summarizes key points from several of these publications and discusses considerations for clinical laboratories, staffed by the unsung heroes responsible for conducting critical testing each day.
For inquiries, please contact:
Lisa Fahey, Director of Marketing, [email protected]
2 Technology Way
Norwood, MA 02062